dm+d
444609007
Refrigerated Storage
KesimptaNovartis Pharmaceuticals
Novartis Pharmaceuticals
Kesimpta
Solution for injection in pre-filled pen
Contact Novartis Pharmaceuticals in all cases where a deviation from the recommended storage conditions has occurred.
Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
25 October 2021
London MI Service
Lactation Safety Information
Low levels anticipated in milk due to the drug's properties which are likely to be degraded in infants GI tract
Long half-life increases risk of accumulation in breastfed infants
Infants should be monitored for signs of infection and immunosuppression
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
16 September 2020